Board Meeting13 Aug 2026, 06:22 pm
Novelix Pharmaceuticals Board Approves Unaudited Q1 FY27 Results
AI Summary
Novelix Pharmaceuticals Ltd announced that its Board of Directors, in a meeting held on August 13, 2026, approved the standalone unaudited financial results for the quarter ended June 30, 2026. The meeting also reviewed the limited review report associated with these results. The company was formerly known as Trimurthi Limited. The board meeting commenced at 5:00 PM and concluded at 5:35 PM.
Key Highlights
- Board meeting held on August 13, 2026.
- Approved standalone unaudited financial results for Q1 FY27.
- Limited Review Report also approved.
- Company formerly known as Trimurthi Limited.
- Results pertain to the quarter ended June 30, 2026.
Price Impact
More from NOVELIX